SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS) and Depomed, Inc. (NASDAQ: DEPO) today announced that supply of GLUMETZA ® 500 mg (metformin HCl extended release tablets ...

Santarus gains broadened rights and responsibility, and Depomed will receive royalties. Santarus and Depomed entered into a new commercialization agreement for type 2 diabetes drug Glumetza (metformin ...

Metformin HCl 500 mg; extended-release tabs. Glumetza extended-release tablets are designed to deliver metformin HCl to the upper GI tract, which may reduce GI side effects often seen with ...

MENLO PARK, Calif. -- Depomed announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for the 1000 mg strength tablets of GlumetzaTM (metformin hydrochloride ...

SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS) and Depomed, Inc. (NASDAQ: DEPO) today announced that they have entered into a promotion agreement granting Santarus ...

Recalls 52 lots of Glumetza 500 mg bottles Says recall not to impact drug's 1000 mg packs Recall due to presence of traces of a chemical Sees recall-related costs up to $2 mln Drug revenue to be hit ...

MENLO PARK, Calif. Depomed has received approval from the Food and Drug Administration for a 1,000 mg strength of Glumetza tablets. Glumetza is used as an adjunct to diet and exercise to improve ...

Depomed, Inc., of Menlo Park, Calif., has received approval for 1,000-mg strength tablets of Glumetza (metformin hydrochloride extended-release tablets), which is indicated alone or in combination ...

Another drug recall underscores the pharma industry's recent manufacturing woes. Depomed has had to withdraw 52 lots of its diabetes drug Glumetza in the 500 mg dose after it found traces of a ...

The Food and Drug Administration has approved Glenmark Pharmaceuticals’ generic of Salix Pharmaceuticals Glumetza (metformin hydrochloride) extended-release tablets. Glenmark’s generic will be ...

Menlo Park, Calif. - June 21, 2011 - Depomed, Inc. (Nasdaq: DEPO) today announced that it has filed a lawsuit in the United States District Court for the District of New Jersey against Sun ...

Menlo Park, Calif. - June 21, 2011 - Depomed, Inc. (Nasdaq: DEPO) today announced that it has filed a lawsuit in the United States District Court for the District of New Jersey against Sun ...